Trimming This Small-Cap Biotech on Strength as We Eye the Chart
Here’s what we’re seeing technically ahead of next week’s earnings.
Here’s what we’re seeing technically ahead of next week’s earnings.
The Fed held rates steady with two hawkish dissents, Oracle’s aggressive long-term targets lifted AI names, but Alphabet fell about 9% after missing expectations.
Plus, Wall Street is taking a new look at SoFi.
A wave of AI-related deals sent semiconductor shares soaring, helping the Nasdaq rally while investors prepared for the Fed and crucial earnings from Microsoft and Google parent Alphabet.
The financial services firm appears to be cooking with gas.
– $MFIC +23% (ARCC agrees to acquire it for $10.88 per share in cash and stock, valuing the transaction at about $2.6B)
– $INIO +14% (record Q3 results and FY26 revenue and EBITDA outlooks were raised)
– $CLS +12% (Q3 beat, FY26 outlook raised and initial 2027 guidance called for 90% revenue growth on accelerating AI-infrastructure demand)
– $SOFI +11% (record Q3 revenue and EBITDA, strong member growth and a raised FY26 outlook)
– $FER +9.9% (no clear fresh catalyst identified; unusually large, liquid move ahead of 9M results after the U.S. close)
– $RCL +5.3% (Q3 beat, bookings remained strong and the full-year profit outlook was raised)
– $CRDO +4.3%, $SKHY +3.2%, $COHR +2.7%, $AMKR +3.6%, $LITE +2.6%, $AVGO +2.9% (AI-chip and optical-connectivity names rise as the CLS outlook reinforces accelerating hyperscaler demand)
– $JCI +4.3% (Q4 beat and the FY27 profit outlook topped expectations)
– $SPGI +3.8% (FY26 outlook raised and a strategic review of Capital IQ businesses was launched)
– $NBIS +3.7%, BE +3.3%, CRWV +3.6%, VRT +2.2% (AI-infrastructure names gain after CLS said customer demand forecasts continue strengthening into 2027 and 2028)
– $NCLH +2.2%, CCL +2.7% (cruise peers rise after RCL beat expectations and raised its full-year profit outlook)
– $CDNS +1.8% (Q3 beat, FY outlook raised, backlog reached a record $8.2B and a $2.5B buyback was added)
– UPS +1.8% (Q3 beat and FY26 revenue and profit forecasts were raised as shipment mix and cost reductions improved)
– $XYL -8.5% (Q3 update disappointed, with investors focusing on softer revenue expectations)
– $WSO -8.3% (Q3 profit missed expectations)
– $HSBC -6.7% (Q3 revenue and pretax profit missed expectations, outweighing a new $1B buyback)
– $HLT -4.4% (Q3 earnings beat, but revenue missed and the raised RevPAR outlook was not enough for elevated expectations)
– $SHW -3.8% (Q3 results and outlook disappointed as housing-linked demand remained soft)
– $ONON -3.3% (no clear fresh catalyst identified; unusually large, high-volume premarket decline)
– $MAR -2.0% (hotel peer slips in sympathy with HLT after its revenue miss)
We’re sticking with this price target as the chart suggests. a good time to initiate or add.
As Rocket Labs teases, I’m buying more, but lowering my expectations.
It’s counterintuitive, but if more people turn bearish, then there is more fuel for a rally as those investors jump back into the market.
We’re moving price targets on three small-cap names amid technical developments.